Literature DB >> 14613898

Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.

Hiromichi Matsumoto1, Takiko Daikoku, Haibin Wang, Eimei Sato, S K Dey.   

Abstract

Development of the blastocyst to implantation competency, differentiation of the uterus to the receptive state, and a cross talk between the implantation-competent blastocyst and the uterine luminal epithelium are all essential to the process of implantation. In the present investigation, we examined the possibility for a potential cross talk between the blastocyst and uterus involving the ezrin/radixin/moesin (ERM) proteins and ERM-associated cytoskeletal cross-linker proteins CD43, CD44, ICAM-1, and ICAM-2. In normal Day 4 blastocysts and after rendering dormant blastocysts to implantation-competent by estrogen in vivo (activated), the outer surface of mural trophectoderm cells showed much higher levels of radixin as compared to those in the polar trophectoderm cells, inner cell mass (ICM), and primitive endoderm. In contrast, ezrin was present on both the mural and the polar trophectoderm cell surfaces of normal Day 4 and activated blastocysts at higher intensity than dormant blastocysts. A distinct localization was noted in the primitive endoderm of dormant blastocysts that was not apparent in activated or normal Day 4 blastocysts. The expression of moesin was modestly higher at the mural trophectoderm of implantation-competent blastocysts, while the localization appeared to be present primarily on the polar trophectoderm cell surface of Day 4 blastocysts. The localization of ERM-associated adhesion molecules CD43, CD44, and ICAM-2 was more intense in the implantation-competent blastocysts compared with the dormant blastocysts. However, while CD44 was present both in the trophectoderm and in ICM, CD43 and ICAM-2 were localized primarily to the trophectoderm. The signal for ICAM-1 was very intense in the ICM but was modest in the trophectoderm. No significant changes in fluorescence intensity were noted between activated and dormant blastocysts. In the receptive uterus on Day 4 of pregnancy, ERM proteins were localized to the uterine epithelium, while on Day 5 the localization, especially of radixin and moesin, extended to the stroma surrounding the implantation chamber. With respect to ERM-associated adhesion molecules, while CD44 and ICAM-1 were exclusively localized in the stroma on Day 4, CD43 and ICAM-2 were localized to the epithelium. On Day 5, the localization of CD44 and ICAM-1 became highly concentrated in the antimesometrial stroma of the implantation chamber. The localization of CD43 and ICAM-2 remained mostly epithelial, although some stromal localization of CD43 was noted on Day 5. These results suggest that differential expression and distribution of ERM proteins and ERM-associated adhesion molecules are involved in the construction of the cellular architecture necessary for blastocyst activation and uterine receptivity leading to successful implantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613898     DOI: 10.1095/biolreprod.103.022764

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  11 in total

1.  CD43 is relocated from the basal to the apical plasma membrane of rat uterine epithelial cells by progesterone.

Authors:  L Lecce; Y Kaneko; C R Murphy
Journal:  Histochem Cell Biol       Date:  2010-03-24       Impact factor: 4.304

2.  Totipotency: what it is and what it is not.

Authors:  Maureen L Condic
Journal:  Stem Cells Dev       Date:  2014-02-12       Impact factor: 3.272

Review 3.  Molecular and cellular events involved in the completion of blastocyst implantation.

Authors:  Hiromichi Matsumoto; Emiko Fukui; Midori Yoshizawa
Journal:  Reprod Med Biol       Date:  2015-08-15

4.  Uterine RAC1 via Pak1-ERM signaling directs normal luminal epithelial integrity conducive to on-time embryo implantation in mice.

Authors:  Z Tu; Q Wang; T Cui; J Wang; H Ran; H Bao; J Lu; B Wang; J P Lydon; F DeMayo; S Zhang; S Kong; X Wu; H Wang
Journal:  Cell Death Differ       Date:  2015-07-17       Impact factor: 15.828

5.  Early developing pig embryos mediate their own environment in the maternal tract.

Authors:  Carmen Almiñana; Paul R Heath; Stephen Wilkinson; Jonatan Sanchez-Osorio; Cristina Cuello; Inmaculada Parrilla; Maria A Gil; Jose L Vazquez; Juan Maria Vazquez; Jordi Roca; Emilio A Martinez; Alireza Fazeli
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  cDNA microarray analysis of bovine embryo gene expression profiles during the pre-implantation period.

Authors:  Koichi Ushizawa; Chandana B Herath; Kanako Kaneyama; Satoshi Shiojima; Akira Hirasawa; Toru Takahashi; Kei Imai; Kazuhiko Ochiai; Tomoyuki Tokunaga; Yukio Tsunoda; Gozoh Tsujimoto; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2004-11-24       Impact factor: 5.211

Review 7.  Molecular and cellular events during blastocyst implantation in the receptive uterus: clues from mouse models.

Authors:  Hiromichi Matsumoto
Journal:  J Reprod Dev       Date:  2017-06-22       Impact factor: 2.214

8.  Inactivation of porcine interleukin-1β results in failure of rapid conceptus elongation.

Authors:  Jeffrey J Whyte; Ashley E Meyer; Lee D Spate; Joshua A Benne; Raissa Cecil; Melissa S Samuel; Clifton N Murphy; Randall S Prather; Rodney D Geisert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

9.  Candidate genes for infertility: an in-silico study based on cytogenetic analysis.

Authors:  Jatinder Singh Sahota; Bhavna Sharma; Kamlesh Guleria; Vasudha Sambyal
Journal:  BMC Med Genomics       Date:  2022-08-02       Impact factor: 3.622

10.  Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus.

Authors:  Xing Li; Wang-Ming Xu; Tai-Lang Yin; Qing-Hong Zhao; Liang-Yu Peng; Jing Yang
Journal:  Int J Mol Sci       Date:  2012-12-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.